A new review has analysed the potential of the polyphenol Epigallocatechin-3-gallate (EGCG) to address microbial dysbiosis in children with Autism Spectrum Disorder (ASD).
Free radicals in phytochemicals are noted for their neuroprotective actions but the clinical effectiveness of antioxidants in ischemic stroke is still unknown, a review has concluded.
